| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Richard A. Heyman is Director at ORIC and has filed Form 4s across 3 companies. From April 2020 to October 2026, the filings on record show 0 open-market purchases and 32 sales. Richard A. Heyman's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.3M at current prices.
Historically, Richard A. Heyman's trades have earned a strong insider score of 73/100 across 42 rated trades. Over a 12-month horizon, 77.1% of those trades were profitable, with an average 12-month return of +35.1%.
The biggest single holding is ORIC (~$2.3M) as Director. The ORIC filings lean toward selling, a net 38,028 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2021 | ORIC Oric Pharmaceuticals, Inc. | Director | Sell | 200 | $25.17 | $5,034.00 | - | -28.7% | -86.2% | |
| Apr 1, 2021 | ORIC Oric Pharmaceuticals, Inc. | Director | Sell | 100 | $25.00 | $2,500.00 | - | -23.8% | -71.6% |